Status:
COMPLETED
Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Minimal Hepatic Encephalopathy
Eligibility:
All Genders
18+ years
Brief Summary
Minimal hepatic encephalopathy (MHE) is a subclinical complication of liver cirrhosis with a relevant social impact. Thus, there is urgent need to implement easy to use diagnostic tools for the early ...
Eligibility Criteria
Inclusion
- diagnosis of liver cirrhosis on the basis of clinical, laboratory and ultrasound findings
Exclusion
- active alcohol abuse (excessive alcohol intake stopped more than 6 months before the enrollment);
- chronic pulmonary diseases; ongoing infections; cerebrovascular diseases; primary or secondary cerebral neoplasm; primary liver neoplasm; heart function failure; chronic kidney disease; peripheral vascular disease; treatment with rifaximin or systemic antibiotics in the previous 15 days;
- smoking habit;
- grade 1 or overt hepatic encephalopathy.
Key Trial Info
Start Date :
January 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04077125
Start Date
January 18 2018
End Date
March 1 2019
Last Update
September 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Agostino Gemelli IRCCS
Roma, Italy, 00168